www.fdanews.com/articles/114245-cephalon-licenses-lupus-drug-candidate

Cephalon Licenses Lupus Drug Candidate

February 2, 2009

Cephalon Inc. said it is exercising an option to worldwide licensing rights to a lupus drug that is under development, triggering a $30 million fee to ImmuPharma PLC.
MSN Money